PHAR - Latest News
Pharming Group N.V. (PHAR), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $828.1M. Trailing twelve-month P/E ratio is 87.28. Beta to the broader market is 0.09.
The article list below shows the most recent PHAR headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent PHAR Headlines
Pharming announces commercial launch of Joenja (leniolisib) in Japan for adult and pediatric patients with APDS aged 4 and older
globenewswire.com - Aug 13, 2026
Launch marks first commercial availability of Joenja (leniolisib) for children aged 4 to 11 worldwide OrphanPacific, Inc. serves as Marketing Authori
Pharming Group (PHAR) Securities Investigation Notice - Levi & Korsinsky
prnewswire.com - Aug 7, 2026
Pharming Group told investors to expect up to $425 million in 2026 revenue. The Company now expects as little as $375 million -- and the stock lost 2
Ratio makes improved bid for Pharos Energy
proactiveinvestors.co.uk - Aug 7, 2026
Ratio Petroleum Energy has raised its recommended offer for Pharos Energy (LSE:PHAR) to 32. 8183p per share, trumping a rival bid from Serica Energy P
Securities Fraud Investigation Into Pharming Group N.V. (PHAR) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
businesswire.com - Aug 6, 2026
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced
Pharming Group N.V. (PHAR) Shareholders Who Lost Money -- Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
gurufocus.com - Aug 6, 2026
Law Offices of Howard G. Smith announces an investigation on behalf of Pharming Group N.
How News Affects PHAR Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track PHAR's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked PHAR news questions
- What is the latest PHAR news headline?
- The most recent PHAR headline (Aug 13, 2026) is "Pharming announces commercial launch of Joenja (leniolisib) in Japan for adult and pediatric patients with APDS aged 4 and older". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the PHAR news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What PHAR news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual PHAR options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.